NCT07058246

Brief Summary

The objective of this study is to evaluate the effectiveness of mime therapy and conventional therapy for improving facial functional mobility and coordination.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 30, 2025

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 10, 2025

Completed
Last Updated

July 10, 2025

Status Verified

July 1, 2025

Enrollment Period

2 months

First QC Date

May 30, 2025

Last Update Submit

July 5, 2025

Conditions

Keywords

Bell PalsyRehabilitation

Outcome Measures

Primary Outcomes (1)

  • Facial Disability Index

    it includes physical well being scale which consist of 5 questions with a 0-5 scoring and social functional scale which consist of 5 questions with a 1-6 scoring.

    4 months

Secondary Outcomes (1)

  • House Brackmann Facial Grading Scale

    4 months

Study Arms (2)

Group A

EXPERIMENTAL

Group A is the experimental group having 17 participants randomly chosen by using coin toss method according to inclusion and exclusion criteria. Baseline Treatment include DL2 electric stimulation at 20-50Hz for 90 repetitions and Infrared lamp placed 30-45cm away from the body for 10-15 minutes. Mime Therapy along with Conventional Therapy.

Other: Mime therapy with Conventional therapy

Group B

ACTIVE COMPARATOR

Group B is the active comparator group having 17 participants randomly chosen by using coin toss method according to inclusion and exclusion criteria. Baseline Treatment include DL2 electric stimulation at 20-50Hz for 90 repetitions and Infrared lamp placed 30-45cm away from the body for 10-15 minutes. Conventional Therapy.

Other: Conventional therapy

Interventions

Experimental group was given mime therapy along with conventional therapy. Mirror therapy, Raising eyebrows as if surprised, Widening eyes in shock, blinking rapidly, Extreme smiling, Eye closure with dramatic expressions, exaggeration nose wrinkling. pouting and mouth opening, expression transitions. Total sessions given are 4-5 per week in 3 weeks consist of 45 mins. Number of repetitions are 5-10 with the hold of 5 second x 2 sets.

Group A

Raising and lowering eyebrows, Wrinkling nose, smiling, frowning, massage. Total sessions given are 4-5 per week in 3 weeks consist of 45 mins. Number of repetitions are 5-10 with the hold of 5 second x 2 sets.

Group B

Eligibility Criteria

Age25 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patient diagnosed with acute bell's palsy
  • All genders and intact taste sensations
  • No other neurological deficit involving face

You may not qualify if:

  • Uncontrolled hypertension
  • Stroke patients
  • Patient with mental and dental implants
  • Patient with recurrent facial palsy
  • Patient with tumors, congenital defects, open wound

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al Raee Hospital

Gujranwala, Punjab Province, 52250, Pakistan

Location

Related Publications (1)

  • Beurskens CH, Heymans PG. Mime therapy improves facial symmetry in people with long-term facial nerve paresis: a randomised controlled trial. Aust J Physiother. 2006;52(3):177-83. doi: 10.1016/s0004-9514(06)70026-5.

    PMID: 16942452BACKGROUND

Related Links

MeSH Terms

Conditions

Bell Palsy

Condition Hierarchy (Ancestors)

Herpesviridae InfectionsDNA Virus InfectionsVirus DiseasesInfectionsMouth DiseasesStomatognathic DiseasesFacial Nerve DiseasesCranial Nerve DiseasesNervous System Diseases

Study Officials

  • Rimza Safdar, DPT

    Elite College of Management sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2025

First Posted

July 10, 2025

Study Start

April 1, 2025

Primary Completion

June 1, 2025

Study Completion

July 1, 2025

Last Updated

July 10, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations